Only thing that might kick start decent share value growth is pray strong interest in Mithra's new contraceptive pill e4 if this were to translate into enough actual sales probably give enough incentive for investors to buy in Mayne . Company's diabolical track record for retail share holders last 5 years it'll need something pretty significant to happen . Optimistic projected earnings earnings " game changing talk" wont cut it means nothing when there's no credibility . Seeing is believing , think company needs to show a net profit report now cant see that happening any time soon especially now we have all the associated Nextstellis costs , better hope it proves a profitable investment it'll have to be cant see how we can afford it not to be , we know it'll be us holding the bag if this is another SR investment gone wrong . Say there'd be plenty sitting on the fence waiting to find out , shares in limbo for good reason given SR / board track record last 5 years .
- Forums
- ASX - By Stock
- Ann: 2022 Half Year Investor Presentation
Only thing that might kick start decent share value growth is...
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.36 |
Change
-0.090(1.65%) |
Mkt cap ! $459.4M |
Open | High | Low | Value | Volume |
$5.43 | $5.59 | $5.35 | $1.040M | 190.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 5281 | $5.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.37 | 1244 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2228 | 5.360 |
14 | 3522 | 5.350 |
10 | 4825 | 5.340 |
7 | 3443 | 5.330 |
3 | 899 | 5.320 |
Price($) | Vol. | No. |
---|---|---|
5.370 | 1718 | 12 |
5.380 | 710 | 4 |
5.390 | 5574 | 6 |
5.400 | 2018 | 3 |
5.410 | 568 | 3 |
Last trade - 15.24pm 22/05/2024 (20 minute delay) ? |
|
|||||
Last
$5.35 |
  |
Change
-0.090 ( 2.25 %) |
|||
Open | High | Low | Volume | ||
$5.40 | $5.59 | $5.35 | 142443 | ||
Last updated 15.43pm 22/05/2024 ? |
Featured News
MYX (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online